Get the Stockscreener App
7.49
0.94%
0.07
After Hours:
7.86
0.37
+4.94%
Aura Biosciences Inc Stock (AURA) Latest News
Learn to Evaluate (AURA) using the Charts - Stock Traders Daily
Aura Biosciences (AURA) to Release Quarterly Earnings on Wednesday - Defense World
Teladoc (TDOC) Harnesses AI for Diabetes Care, Stock Rises 6.7% - MSN
Tarsus Pharmaceuticals (NASDAQ:TARS) & Aura Biosciences (NASDAQ:AURA) Critical Survey - Defense World
H.C. Wainwright maintains $22 target on Aura Biosciences stock By Investing.com - Investing.com UK
Buy Rating for Aura Biosciences Driven by Promising Bel-sar Developments and Market Potential - TipRanks
Promising Developments in Aura Biosciences Inc’s Clinical Trials Lead to Buy Rating - TipRanks
Aura Biosciences to present new bladder cancer study data - Investing.com
Aura Biosciences to Present Phase 1 Data on Bel-sar and Host Virtual Urologic Oncology Investor Event at 40th Annual EAU Congress - Nasdaq
Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology Congress - GlobeNewswire
Will Aura's Bladder Cancer Treatment Change Patient Outcomes? New Data Coming in 2025 - StockTitan
How to Take Advantage of moves in (AURA) - Stock Traders Daily
Syndax Announces Participation in March Investor Conferences - The Manila Times
Aura Biosciences to Participate in Upcoming Investor Conferences - GlobeNewswire
How Will Aura Biosciences Address Investors at Two Major Healthcare Conferences Next Month? - StockTitan
Advancing Immunotherapy With FDA Approval Of ANKTIVA For BCG-Unresponsive Bladder Cancer: Key Trend Transfo... - WhaTech
Brokerages Set Aura Biosciences, Inc. (NASDAQ:AURA) Target Price at $23.00 - Defense World
Aura Biosciences CEO sells shares worth $156,795 - Investing.com India
Aura Biosciences chief medical officer sells $19,638 in stock By Investing.com - Investing.com South Africa
Aura Biosciences CEO sells shares worth $156,795 By Investing.com - Investing.com Nigeria
Aura Biosciences CTO sells shares for $16,670 By Investing.com - Investing.com South Africa
Aura Biosciences senior VP sells $10,881 in stock to cover taxes - Investing.com
Aura Biosciences chief medical officer sells $19,638 in stock - Investing.com
Aura Biosciences Executives Sell Shares to Cover Tax Obligations - TradingView
Non-Muscle Invasive Bladder Cancer (NMIBC) Drugs Market 2034: - openPR
Healthy Upside Potential: Aura Biosciences Inc (AURA) - SETE News
How To Trade (AURA) - Stock Traders Daily
FY2025 Earnings Estimate for AURA Issued By Leerink Partnrs - MarketBeat
Choreo LLC Purchases 187 Shares of Moelis & Company (NYSE:MC) - Defense World
Ocular melanoma Market Expected to Experience Major Growth - openPR
AURAAura Energy Limited September 2020 Quarterly Report (5044E) - br.ADVFN.com
What is Leerink Partnrs’ Estimate for AURA FY2025 Earnings? - Defense World
Research Analysts Issue Forecasts for AURA Q1 Earnings - Defense World
CV Sciences Unveils New Aura Collection THC Fizz Tablets - Yahoo Finance
Aura Biosciences, Inc. (NASDAQ:AURA) Short Interest Update - MarketBeat
Aura Biosciences (NASDAQ:AURA) Rating Increased to Strong-Buy at Lifesci Capital - MarketBeat
Lifesci Capital Upgrades Aura Biosciences (NASDAQ:AURA) to Strong-Buy - Defense World
Investing in Aura Minerals (TSE:ORA) five years ago would have delivered you a 822% gain - Yahoo Finance
JPMorgan Chase & Co. Grows Holdings in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
Financial Analysis: New Concept Energy (NYSE:GBR) versus Riley Exploration Permian (NYSE:REPX) - Defense World
Waystar (NASDAQ:WAY) & Verint Systems (NASDAQ:VRNT) Critical Review - Defense World
Head-To-Head Contrast: Yara International ASA (OTCMKTS:YARIY) vs. Ero Copper (NYSE:ERO) - Defense World
Analysts Set Aura Biosciences, Inc. (NASDAQ:AURA) PT at $23.00 - Defense World
Regency Capital Management Inc. DE Sells 57,887 Shares of Aura Biosciences, Inc. (NASDAQ:AURA) - MarketBeat
Aura Biosciences, Inc. (NASDAQ:AURA) Receives $23.00 Average Target Price from Brokerages - MarketBeat
What is Lifesci Capital’s Estimate for AURA FY2024 Earnings? - Defense World
FY2024 Earnings Forecast for AURA Issued By Lifesci Capital - MarketBeat
Non Muscle Invasive Bladder Cancer Pipeline 2024: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Aura Biosciences, Protara Therapeutics, Vaxiion Therapeutics - Barchart
This Insider Has Just Sold Shares In Aura Biosciences - Simply Wall St
Where are the Opportunities in (AURA) - Stock Traders Daily
Non Muscle Invasive Bladder Cancer Pipeline 2024: MOA, ROA, - openPR
Aura Biosciences VP Amy Elazzouzi sells $7,679 in stock - MSN
Aura Biosciences, Inc. (NASDAQ:AURA) Insider Sells $122,374.85 in Stock - MarketBeat
Aura Biosciences CEO Elisabet de los Pinos sells shares worth $122,381 - MSN
Aura Biosciences VP Amy Elazzouzi sells $7,679 in stock By Investing.com - Investing.com Australia
2.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):